These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1652256)

  • 1. The urokinase-type plasminogen activator receptor is a member of the Ly-6 superfamily.
    Palfree RG
    Immunol Today; 1991 May; 12(5):170. PubMed ID: 1652256
    [No Abstract]   [Full Text] [Related]  

  • 2. Protein structure and membrane anchorage of the cellular receptor for urokinase-type plasminogen activator.
    Ploug M; Behrendt N; Løber D; Danø K
    Semin Thromb Hemost; 1991 Jul; 17(3):183-93. PubMed ID: 1665583
    [No Abstract]   [Full Text] [Related]  

  • 3. [Structure and characteristics of singer chain urokinase-type plasminogen activator].
    Shi W; Zhang CY
    Sheng Li Ke Xue Jin Zhan; 1990 Oct; 21(4):314-7. PubMed ID: 2129250
    [No Abstract]   [Full Text] [Related]  

  • 4. [The structure and function of urokinase receptor and its expression in neoplastic tissues].
    Tang H; Zhu Y; Song H
    Zhonghua Yi Xue Za Zhi; 1995 May; 75(5):315-7. PubMed ID: 7656166
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification of specific sites involved in ligand binding by photoaffinity labeling of the receptor for the urokinase-type plasminogen activator. Residues located at equivalent positions in uPAR domains I and III participate in the assembly of a composite ligand-binding site.
    Ploug M
    Biochemistry; 1998 Nov; 37(47):16494-505. PubMed ID: 9843416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural analysis of the interaction between urokinase-type plasminogen activator and its receptor: a potential target for anti-invasive cancer therapy.
    Ploug M; Gårdsvoll H; Jørgensen TJ; Lønborg Hansen L; Danø K
    Biochem Soc Trans; 2002 Apr; 30(2):177-83. PubMed ID: 12023847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasminogen activator system in osteoclasts.
    Yang JN; Allan EH; Anderson GI; Martin TJ; Minkin C
    J Bone Miner Res; 1997 May; 12(5):761-8. PubMed ID: 9144342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localization of components from the plasminogen activation system in mammalian tissues.
    Kristensen P
    APMIS Suppl; 1992; 29():1-27. PubMed ID: 1337257
    [No Abstract]   [Full Text] [Related]  

  • 9. Structural and phylogenetic characterization of human SLURP-1, the first secreted mammalian member of the Ly-6/uPAR protein superfamily.
    Adermann K; Wattler F; Wattler S; Heine G; Meyer M; Forssmann WG; Nehls M
    Protein Sci; 1999 Apr; 8(4):810-9. PubMed ID: 10211827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The two subunits of a phospholipase A2 inhibitor from the plasma of Thailand cobra having structural similarity to urokinase-type plasminogen activator receptor and LY-6 related proteins.
    Ohkura N; Inoue S; Ikeda K; Hayashi K
    Biochem Biophys Res Commun; 1994 Nov; 204(3):1212-8. PubMed ID: 7980598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of human single chain urokinase to Chinese Hamster Ovary cells and cloning of hamster u-PAR.
    Fowler B; Mackman N; Parmer RJ; Miles LA
    Thromb Haemost; 1998 Jul; 80(1):148-54. PubMed ID: 9684801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystallization of soluble urokinase receptor (suPAR) in complex with urokinase amino-terminal fragment (1-143).
    Huang M; Mazar AP; Parry G; Higazi AA; Kuo A; Cines DB
    Acta Crystallogr D Biol Crystallogr; 2005 Jun; 61(Pt 6):697-700. PubMed ID: 15930623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of the urokinase receptor by its plasminogen activator.
    Hollas W; Boyd D
    Thromb Haemost; 1991 Dec; 66(6):678-83. PubMed ID: 1665597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Plasminogen activators as thrombolytic agents in myocardial infarction].
    Chamone DA; Massumoto C; Fujimura AY; Pileggi F; Bellotti G
    Rev Hosp Clin Fac Med Sao Paulo; 1989; 44(6):288-94. PubMed ID: 2518605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasminogen activation by receptor-bound urokinase.
    Ellis V; Danø K
    Semin Thromb Hemost; 1991 Jul; 17(3):194-200. PubMed ID: 1665584
    [No Abstract]   [Full Text] [Related]  

  • 16. Expression and localization of the urokinase-type plasminogen activator receptor (uPAR) in the human placenta.
    Nishida Y; Hayashi Y; Imai Y; Itoh H
    Kobe J Med Sci; 1998 Feb; 44(1):31-43. PubMed ID: 9846056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulated localization confers multiple functions on the protease urokinase plasminogen activator.
    Wells JM; Strickland S
    J Cell Physiol; 1997 May; 171(2):217-25. PubMed ID: 9130470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization of the disulfide bonds in the NH2-terminal domain of the cellular receptor for human urokinase-type plasminogen activator. A domain structure belonging to a novel superfamily of glycolipid-anchored membrane proteins.
    Ploug M; Kjalke M; Rønne E; Weidle U; Høyer-Hansen G; Danø K
    J Biol Chem; 1993 Aug; 268(23):17539-46. PubMed ID: 8394346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mechanism of thrombolytic enzymes].
    Matsuo O
    Rinsho Ketsueki; 1993 Apr; 34(4):395-402. PubMed ID: 8510325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimessenger oligonucleotide for urokinase receptor gene inhibits invasivity of transformed human fibroblasts.
    Quattrone A; Fibbi G; Anichini E; Pucci M; Zamperini A; Capaccioli S; Del Rosso M
    Anticancer Drug Des; 1995 Jan; 10(1):97-102. PubMed ID: 7695815
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.